BAA topic 9.2 - effectiveness of influenza & covid-19 vaccines against lab confirmed outpatient illness during 2021-2022 season
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30121C12279
- Awardee
-
Baylor Research Institute UEI J1G9CV11VCN7
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $1,499,900
Award facts
- Contract value 100% obligated
- $1,499,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Dallas, TX 75201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,499,900 |
About this award
Baylor Research Institute was awarded a $1,499,900 firm fixed price definitive contract from the Department of Health and Human Services Centers for Disease Control and Prevention to conduct research under Broad Agency Announcement Topic 9.2, which solicited proposals to assess the effectiveness of influenza and COVID-19 vaccines against laboratory-confirmed outpatient illness during the 2021-2022 season. As the prime contractor, Baylor Research Institute will leverage its expertise in public health research to provide medical research services related to vaccine effectiveness from its location in Dallas, Texas. No set-aside designation was used for this contract award made by the CDC to support its ongoing efforts to monitor and improve vaccine programs.
Quick answers
Who was awarded contract 75D30121C12279?
75D30121C12279 was awarded to Baylor Research Institute by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 30, 2021.
How much is contract 75D30121C12279 worth?
The government has obligated $1,499,900 on 75D30121C12279.
Was contract 75D30121C12279 competed?
The extent of competition for 75D30121C12279 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award